SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis

Oncogene

Volumn 32, Issue 35, 2013, Pages 4160-4168

  Yu, E J ^a   Kim, S H ^a,b   Kim, M J ^a   Seo, W Y ^a,c   Song, K A ^a   Kang, M S ^a,c   Yang, C K ^d   Stallcup, M R ^d   Kim, J H ^a,c  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

breast cancer; co activator; CoCoA; SUMOylation; ZFP282

Indexed keywords

BINDING PROTEIN; COCOA BINDING PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 282;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BREAST; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; GENE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SUMOYLATION;

BREAST NEOPLASMS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; SIGNAL TRANSDUCTION; SUMOYLATION; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; ZINC FINGERS;

THEOBROMA CACAO;

EID: 84883488216     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.420     Document Type: Article

References (23)

1. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8: 947-956.
2. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev 2005; 15: 536-541.
3. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451-486.
4. Stallcup MR, Kim JH, Teyssier C, Lee YH, Ma H, Chen D. The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators. J Steroid Biochem Mol Biol 2003; 85: 139-145.
5. Kim JH, Li H, Stallcup MR. CoCoA a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. Mol Cell 2003; 12: 1537-1549.
6. Kim JH, Yang CK, Stallcup MR. Downstream signaling mechanism of the C-terminal activation domain of transcriptional coactivator CoCoA. Nucleic Acids Res 2006; 34: 2736-2750.
7. Kim JH, Yang CK, Heo K, Roeder RG, An W, Stallcup MR. CCAR1 a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol Cell 2008; 31: 510-519.
8. Yu EJ, Kim SH, Heo K, Ou CY, Stallcup MR, Kim JH. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor a activity and co-activator synergy. Nucleic Acids Res 2011; 39: 6932-6943.
9. Okumura K, Sakaguchi G, Naito K, Tamura T, Igarashi H. HUB1 a novel Kruppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expression. Nucleic Acids Res 1997; 25: 5025-5032.
10. Buache E, Etique N, Alpy F, Stoll I, Muckensturm M, Reina-San-Martin B et al. Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 2011; 30: 3261-3273.
11. Li S, Shang Y. Regulation of SRC family coactivators by post-translational modifications. Cell Signal 2007; 19: 1101-1112.
12. Yang CK, Kim JH, Ann DK, Stallcup MR. Differential regulation of the two transcriptional activation domains of the coiled-coil coactivator CoCoA by sumoylation. BMC Mol Biol 2008; 9: 12.
13. Tamura T, Sakata T, Igarashi H, Okumura K. Transcription factor HUB1 represses SP1-mediated gene expression through the CACCC box of HTLV-I U5RE but not the GC box. J Health Sci 2004; 50: 417-422.
14. Chupreta S, Brevig H, Bai L, Merchant JL, Iniguez-Lluhi JA. Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89. J Biol Chem 2007; 282: 36155-36166.
15. Conroy AT, Sharma M, Holtz AE, Wu C, Sun Z, Weigel RJ. A novel zinc finger transcription factor with two isoforms that are differentially repressed by estrogen receptor-alpha. J Biol Chem 2002; 277: 9326-9334.
16. Kuo HY, Chang CC, Jeng JC, Hu HM, Lin DY, Maul GG et al. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc Natl Acad Sci USA 2005; 102: 16973-16978.
17. Girdwood D, Bumpass D, Vaughan OA, Thain A, Anderson LA, Snowden AW et al. P300 transcriptional repression is mediated by SUMO modification. Mol Cell 2003; 11: 1043-1054.
18. Karamouzis MV, Konstantinopoulos PA, Badra FA, Papavassiliou AG. SUMO and estrogen receptors in breast cancer. Breast Cancer Res Treat 2008; 107: 195-210.
19. Mo YY, Yu Y, Theodosiou E, Ee PL, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene 2005; 24: 2677-2683.
20. Sentis S, Le Romancer M, Bianchin C, Rostan MC, Corbo L. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol 2005; 19: 2671-2684.
21. Kotaja N, Karvonen U, Janne OA, Palvimo JJ. The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem 2002; 277: 30283-30288.
22. Wu H, Sun L, Zhang Y, Chen Y, Shi B, Li R et al. Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J Biol Chem 2006; 281: 21848-21856.
23. Uchimura Y, Nakamura M, Sugasawa K, Nakao M, Saitoh H. Overproduction of eukaryotic SUMO-1-and SUMO-2-conjugated proteins in Escherichia coli. Anal Biochem 2004; 331: 204-206.